e-learning
resources
Vienna 2009
Monday, 14.09.2009
Models of chronic airways disease and therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung reactivity to a new hybrid piridin-phenothiazinic derivative in rats
C. Zamfir, C. C. Grigoras, A. Grigoras, E. Cojocaru, C. Lupusoru, E. Bicu (Iasi, Romania)
Source:
Annual Congress 2009 - Models of chronic airways disease and therapy
Session:
Models of chronic airways disease and therapy
Session type:
Thematic Poster Session
Number:
2071
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Zamfir, C. C. Grigoras, A. Grigoras, E. Cojocaru, C. Lupusoru, E. Bicu (Iasi, Romania). Lung reactivity to a new hybrid piridin-phenothiazinic derivative in rats. Eur Respir J 2009; 34: Suppl. 53, 2071
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
A molecule derived from mycobacterium tuberculosis
Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
New synthetic compound cyclohexylmethoxy derivative inhibits asthmatic reaction in mouse model
Source: Eur Respir J 2005; 26: Suppl. 49, 213s
Year: 2005
The benefit of new antileukotriene derivatives on airway responsiveness in ovalbumin-sensitized rats
Source: Eur Respir J 2004; 24: Suppl. 48, 219s
Year: 2004
Lung ageing in C57/Bl6 and BALB/c mice is characterized by a defective surfactant metabolism, increased ER stress and inflammasome induction
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Differences in lung and chest wall contributions to respiratory system mechanics: comparison of mice, rats and rabbits
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019
Investigation of the feasibility of manufacturing a spray-dried formulation of the synthetic peptide, AP301
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014
Lung function in intubated mice can be measured repeatedly
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
Lung tumor growth quantification in transgenic mice using μCT and μPET
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008
Inhaled silver nanoparticles induce pulmonary oxidative injury and inflammation: Differential effects between rat strains
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Prevention of ischemia-reperfusion lung injury by supplementation of the preservation solution with an oxygen carrier in porcine lung transplant model
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006
Altered extracellular matrix in transplanted lungs as a potential marker for chronic rejection
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Determinants of inflammatory and functional toxicity of silver nanospheres in rat lung
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Effects of exercise on lung inflammation in ovalbumin-sensitized and single challenged mice
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012
Gene expression profile of pulmonary inflammation in rat lung induced by nickel oxide nanoparticles following intratracheal instillation
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Effect of POL6014, a protein epitope mimetic (PEM) neutrophil elastase inhibitor, in a model of monocrotaline (MCT)-induced pulmonary arterial hypertension in rats
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013
Ex vivo elastase and hydrogen peroxide stimulation in lung slices: novel models to study lung repair
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Lung mechanics in fawn-hooded rats (FHR)
Source: Eur Respir J 2001; 18: Suppl. 33, 257s
Year: 2001
The novel oligonucleotide therapeutics PK-7010 for TGF-ß1 ameliorates bleomycin-induced pulmonary fibrosis in mice
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Effect of experimental pulmonary fibrosis induced by bleomycin on the lung fatty acid composition in Wistar rats
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept